ACHIEVE Hearing Intervention Follow-Up Study

Summary

The ACHIEVE Hearing Intervention Follow-Up study is a randomized trial of a telehealth versus conventional clinic-based hearing healthcare (HHC) delivery model among older adults who are existing hearing aid users to determine if a telehealth HHC model improves hearing aid use and other communication outcomes compared to clinic-based HHC.

Conditions

• Hearing Loss
• Aging

Interventions

OTHER

Clinic-based audiological rehabilitative service delivery

Participants will have scheduled clinic-based visits at 6 and 12 months post-randomization to reinforce self-management strategies and perform hearing aid checks.

OTHER

Telehealth audiological rehabilitative service delivery

Participants' scheduled clinic-based visits will be complemented with asynchronous and synchronous telehealth that will allow for routine troubleshooting of communication challenges, hearing aid technical issues, and reinforcement of self-management support strategies. At an initial session, participants will be instructed in the use of a study-provided, internet-enabled tablet device for telehealth sessions, re-introduced to the hearing loss toolkit for self-management and C2Hear Reusable Learning Objects within the context of the telehealth platform, re-evaluated on the Client Oriented Scale of Improvement (COSI) goals. Two remote follow-up sessions will be scheduled 3 and 6 weeks later to confirm participants' comfort with the telehealth platform and then completed every 6 months, in addition to scheduled 6-month clinic-based visits.

Sponsors & Collaborators

• University of North Carolina

  collaborator OTHER

• University of South Florida

  collaborator OTHER

• University of Minnesota

  collaborator OTHER

• University of Mississippi Medical Center

  collaborator OTHER

• Wake Forest University

  collaborator OTHER

• National Institute on Deafness and Other Communication Disorders (NIDCD)

  collaborator NIH

• NYU Langone Health

  collaborator OTHER

• Johns Hopkins University

  lead OTHER

Principal Investigators

• Frank R Lin, MD, PhD · Johns Hopkins University

• Victoria A Sanchez, AuD, PhD · University of South Florida

Study Design

Allocation

RANDOMIZED

Purpose

HEALTH_SERVICES_RESEARCH

Masking

NONE

Model

PARALLEL

Eligibility

Min Age

73 Years

Max Age

88 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2021-11-12

Primary Completion

2024-01-10

Completion

2025-06-19

Countries

• United States

Study Locations